<p>This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Omneuron Inc., a for-profit subchapter S corporation. The contract is for "MOBILE TECHNOLOGY FOR SUBSTANCE USE DISORDERS" with a performance period from September 15, 2015 to March 14, 2016. It is a firm-fixed-price definitive contract with a ceiling value of $150,000.00. The contract was set aside for small businesses.</p>
This is a $275,942.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to My Own Med, Inc., a woman-owned small business. The contract is for the SBIR 136 - MY OWN MED project, which involves providing the M2Study Platform, consisting of the MyOwnMed Mobile App with a COVID-19 symptom tracker and the MyOwnMed Portal for database analytics. This platform has been utilized in support of a Software as a Service (SaaS) agreement...
This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Webmd Health Corp. (Webmd) on September 1, 2016. The contract, awarded under a Broad Agency Announcement (BAA) titled "CLINICAL TRIAL RECRUITMENT BIAS PATIENT CHOICE ANALYSIS", has a ceiling value of $506,289.95 and a completion date of September 30, 2019. The contract is a firm fixed-price arrangement and does not have a...
This contract award, valued at $141,506.60, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. It was awarded to A Square Group LLC (doing business as ASG), a woman-owned small business. The contract is a Delivery Order placed under the General Services Administration's Information Technology Schedule 70 contract vehicle. The contract is for the development of a mobile psychological application. It has a firm...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $600,820.00 firm fixed-price definitive contract to WebMD Health Corp. to conduct a "Study of Comparative Effectiveness of Disease Education Messaging." The contract does not have a set-aside designation. WebMD, a for-profit organization, operates the Medscape platform providing medical education and news to clinicians. Through this contract, WebMD will deliver online assessment tools,...
This is a Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Icallidus, Inc., a minority-owned, self-certified small disadvantaged business and economically disadvantaged woman-owned small business. The contract, valued at $119,185.51, is for the development of a mobile application to verify age from identification (ID) cards for tobacco sales. The contract has no set-aside designation and has an ultimate completion date of May 3, 2018....
This is a $4,690,787.31 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Team TECH Iyka Joint Venture LLC, a minority-owned, self-certified small disadvantaged business. The contract was awarded on March 21, 2016 and has an ultimate completion date of September 21, 2019. It is an 8(a) sole source contract for "OTHER FUNCTION - ASR EDR ECTD", though the specific products or services being provided are not detailed. The...
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response has awarded a $338,196.00 Firm Fixed Price contract to Tele-Stethoscope Inc., a self-certified small disadvantaged business, for research and development related to digital multi-channel monitors (MCMs) that can detect respiratory diseases using mobile phones. The contract has an ultimate completion date of September 14, 2024. This award is not associated with a larger...
This federal contract award, with ID HHSF223201610616A, was issued by the Food and Drug Administration (FDA) to Lake Research Partners, Inc., a small disadvantaged woman-owned business. The contract, with a ceiling value of $287,814.40, is for MCM (Medical Countermeasures) studies to enhance FDA communications. The contract has a firm fixed-price structure and a completion date of February 28, 2019. The place of performance is Washington, DC. This contract award is not associated with a larger...
This is a Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Medable Inc., a self-certified small disadvantaged business. The $1,724,094.00 Firm Fixed Price contract is for the DIGIBIOMARC: DIGITAL BIOMARKERS FOR CLINICAL IMPACT- MOONSHOT PROJECT (FAST TRACK), which was a pre-solicitation set aside for small businesses. The contract was awarded on September 17, 2018 with a completion date of June 30, 2022. The...